SERI Using TripleTOF 5600 to Validate Protein Biomarker for Dry Eye Syndrome | GenomeWeb

By Adam Bonislawski

Researchers at the Singapore Eye Research Institute have identified six peptide biomarkers linked to dry eye syndrome, which they plan to validate in a 400-patient trial done in collaboration with ocular pharmaceutical company Allergan using AB Sciex's TripleTOF 5600 mass spectrometer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.